orexigen therapeutics inc
(OREX:Consolidated Issue Listed on NASDAQ Global Select )
Peter K. Honig M.D., MPH
Director and Chairperson of Research & Development Strategy Committee,Orexigen Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Peter K. Honig, MD, MPH, serves as the Head of Global Regulatory Affairs at AstraZeneca, Inc. Dr. Honig served as a Senior Vice President of Worldwide Regulatory Affairs and Product Safety at Merck & Company. He has over 20 years of clinical and regulatory policy experience from past roles with Merck & Company and the U.S. Food and Drug Administration (FDA). He served as Merck's Vice President, Worldwide Product Safety and Quality Assurance. He originally joined ...
3344 North Torrey Pines CourtPhone: 858-875-8600
La Jolla, California 92037
Board Members Memberships*
Director and Chairperson of Research & Development Strategy Committee
Non-Employee Director and Member of Nominating & Corporate Governance Committee
Edward S. Harkness Eye Institute
Mailman School of Public Health, Columbia University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer|
Arena Pharmaceuticals, Inc.
|Seth H. Z. Fischer||Chief Executive Officer, Chief Commercial Officer and Director|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Lars Rebien Sørensen||Chief Executive Officer, President and Member of Executive Management|
Novo Nordisk A/S
|kr15.2M||Compensation as of Fiscal Year 2014.|